Noticias de UTHR_US

Mercado

Noticias del mercado

Últimas noticias sobre UTHR_US — 297 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: UTHR_US ✕ 297 resultados
26/09/2026 UTHR_US — Investing.com
United Therapeutics chairperson & CEO sells $4.7m in stock
25/09/2026 UTHR_US — ChartMill ES ← CY
Noticias UTHR | UNIDOS TERAPÉUTICOS CORP (NASDAQ:UTHR)

UTHR News | UNITED THERAPEUTICS CORP (NASDAQ:UTHR)

25/09/2026 UTHR_US — Stock Titan
After exercising stock options, the CEO's family trust sold 9,500 United Therapeutics (UTHR) shares.
25/09/2026 UTHR_US — Yahoo Finance
United Therapeutics Maps 14 Launches, Fibrosis Growth and Xenokidney Ambitions

United Therapeutics (NASDAQ:UTHR) outlined plans to expand its pulmonary fibrosis, pulmonary hypertension and organ-manufacturing businesses at the Bernstein Healthcare Leaders and Disruptors Conference, with management describing a pipeline of 14 prospective product launches and continued share rep

24/09/2026 UTHR_US — Investing.com
United Therapeutics CEO Rothblatt sells $4.67m in stock after option exercise
24/09/2026 UTHR_US — Investing.com
Goldman Sachs initiates United Therapeutics stock with sell rating By Investing.com
24/09/2026 UTHR_US — Investing.com
Goldman Sachs initiates United Therapeutics stock with sell rating By Investing.com
24/09/2026 UTHR_US — Investing.com
Goldman Sachs initiates United Therapeutics stock with sell rating By Investing.com
24/09/2026 UTHR_US — Investing.com
Goldman Sachs initiates United Therapeutics stock with sell rating By Investing.com
24/09/2026 UTHR_US — Stock Titan
After exercising 9,500 options, family trusts sold United Therapeutics (UTHR) shares under a pre-arranged plan.
24/09/2026 UTHR_US — ChartMill
United Therapeutics (NASDAQ:UTHR): A Growth-at-a-Reasonable-Price Candidate
24/09/2026 UTHR_US — GuruFocus
A Look at United Therapeutics Corp (UTHR) After 3.5% Decline -- GF Value $427.97 vs Price $472.21
24/09/2026 UTHR_US — Investing.com
Goldman Sachs initiates United Therapeutics stock with sell rating
24/09/2026 UTHR_US — Investing.com
United Therapeutics CEO Rothblatt sells $4.67m in stock after option exercise
23/09/2026 UTHR_US — GuruFocus ES ← EN
Transcripción de United Therapeutics Corporation en el Foro Bernstein Healthcare

United Therapeutics Corporation at Bernstein Healthcare Forum Transcript

23/09/2026 UTHR_US — Stock Titan
Under a pre-arranged plan, United Therapeutics (UTHR) CEO’s family trusts exercise 9,500 options and sell the shares.

Los fideicomisos vendieron acciones en diez transacciones a precios promedio ponderados de $489,6121 a $499,0681. El saldo de opciones informado posteriormente fue de 385.410.

22/09/2026 UTHR_US — Investing.com
United Therapeutics CEO Rothblatt sells $4.7m in stock By Investing.com
22/09/2026 UTHR_US — Investing.com
United Therapeutics CEO Rothblatt sells $4.7m in UTHR shares By Investing.com
22/09/2026 UTHR_US — Investing.com
United Therapeutics CEO Rothblatt sells $4.7m in UTHR shares By Investing.com
22/09/2026 UTHR_US — Investing.com
United Therapeutics CEO Rothblatt sells $4.7m in UTHR shares By Investing.com

Página 7 de 15